ouabain has been researched along with fulvestrant in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson-Lendahl, M; Balaguer, P; Bernard, L; Cravedi, JP; Demeneix, B; Fini, JB; Gibert, Y; Laudet, V; Sassi-Messai, S; Zalko, D | 1 |
| Acconcia, F | 1 |
2 other study(ies) available for ouabain and fulvestrant
| Article | Year |
|---|---|
Bisphenol A induces otolith malformations during vertebrate embryogenesis.
Topics: Animals; Benzhydryl Compounds; Embryonic Development; Endocrine Disruptors; Environmental Pollution; Estradiol; Female; Fulvestrant; In Situ Hybridization; Otolithic Membrane; Ouabain; Phenols; Receptors, Estrogen; Receptors, Thyroid Hormone; Sodium-Potassium-Exchanging ATPase; Thyroid Hormones; Water Pollutants; Xenopus; Zebrafish | 2011 |
Evaluation of the Sensitivity of Breast Cancer Cell Lines to Cardiac Glycosides Unveils ATP1B3 as a Possible Biomarker for the Personalized Treatment of ERĪ± Expressing Breast Cancers.
Topics: Adenosine Triphosphatases; Anastrozole; Aromatase Inhibitors; Biomarkers; Breast Neoplasms; Cardiac Glycosides; Cell Line, Tumor; Epidermal Growth Factor; ErbB Receptors; Erlotinib Hydrochloride; Estradiol; Estrogen Receptor alpha; Female; Fulvestrant; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Lapatinib; Letrozole; MCF-7 Cells; Ouabain; Precision Medicine; Sodium-Potassium-Exchanging ATPase; Tamoxifen | 2022 |